C.RIS Pharma - Company Review
SummaryC.RIS Pharma - Company Review
Summary
C.RIS Pharma (C.RIS) is a contract research organization that provides in vitro and in vivo preclinical development. The organization’s services include characterization of molecule activity, identification and validation of therapeutic target, toxicology and metabolism cosmetic studies and agrofood studies. Its characterization of molecule activity offers anti-angiogenic effects, anti-hormonal effects, cytotoxicity, hematotoxicity, clonogenic assay and apoptosis studies. C.RIS offers services in the fields of cancer, neurodegenerative, metabolic and genetic disease. The organization caters to pharmaceutical and biotechnology companies. Its research and development sector develops new method to characterize the drug mechanism. C.RIS is headquartered in Saint Malo, France.
This comprehensive company report of C.RIS Pharma provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.